Health knowledge made personal
WellPage for Epoetin Alfa
+ Bookmark › Share
Email Digg del.icio.us Reddit icon StumbleUpon Technorati
Go
Search posts:

Epoetin Alfa - Articles

Epogen and Procrit (epoetin alfa): Recall - Particulate Matter in Vials by FDA Posted Fri 24 Sep 2010 4:48pm [Posted 09/24/2010] AUDIENCE: Risk Manager, Oncology, Nephrology ISSUE: Amgen and FDA notified healthcare professionals that certain lots of Epogen and Procrit (Epoetin alfa) vials are being recalled as a precaution, because the vials may contain extremely thin glass flakes (lamellae) that are barely visible Read on »
Amgen Initiates Voluntary Nationwide Recall Of Certain Lots Of Epogen® And Procrit® (Epoetin Alfa) by FDA Posted Fri 24 Sep 2010 4:27pm ® (Epoetin alfa) vials are being voluntarily recalled from specialty distributors, wholesalers, pharmacies and healthcare providers as a precaution. The product that is being recalled... Biotech Products is the authorized distributor of PROCRIT in the United States. About EPOGEN (Epoetin alfa) EPOGEN is indicated for the treatment of anemia in patients Read on »
Anemia in Kidney Failure and Dialysis Patients by julius Patient Expert Posted Mon 16 Nov 2009 10:02pm that a patient could save through this option outweighs the dangers. In my case I am taking EPO shots twice a week. I was taking 5000 units of Recormon (Erythropoetin or Epoetin Beta) during my earlier days of treatment. Last year I was shifted to Renogen (Epoetin Alfa). Both drugs treat kidney failure-related anemia. The shift was due to economical reasons Read on »
New Warnings for Erythropoiesis-stimulating agents (ESAs) by Alan T. Patient Expert Posted Fri 03 Oct 2008 11:31am ? They are injectable drugs, genetically engineered forms of a protein, to boost the production of red blood cells. In Malaysia, ESAs that are available include: darbepoetin alfa epoetin alfa (Eprex) epoetin beta (Recormon) They are used for anemia in chronic kidney failure (epoietin alfa) and also cancer patients (darbepoetin alfa). Anemia Read on »
AARP, ALFA, Technology - what's next in caregiving by Sharon K. Brothers, MSW Healthy Living ProfessionalHealth Maven Posted Fri 17 Oct 2008 9:13pm and heading for the mainstream. We're off today to Dallas for the Assisted Living Federation of America (ALFA) conference to learn what's new in approaches to caregiving Read on »
Anemia Drug May Raise Stroke Ris ... by Dr. Rubens D. Medical Doctor Posted Sat 31 Oct 2009 11:01pm , the researchers noted. In earlier studies, Aranesp and a similar drug, epoetin alfa, marketed as Procrit or Epogen, were linked to increased risk of death in cancer and stroke patients... and kidney disease without substantially improving their quality of life, a new study finds. Darbepoetin alfa, marketed as Aranesp and known as an erythropoiesis-stimulating agent Read on »
FDA Announces New Safety Plan for Agents Used to Treat Chemotherapy-Related Anemia by Health: Hearsay & Headlines Posted Wed 17 Feb 2010 12:00am anemia that can occur as a result of chemotherapy. ESAs, which include epoetin alfa (marketed as Procrit and Epogen) and darbepoetin alfa (marketed as Aranesp), are manufactured Read on »
How serious ARE the side effects of cabazitaxel? by Dr. Arnon Krongrad Medical Doctor Posted Mon 14 Jun 2010 12:00am -stimulating agents (darbepoetin/Aranesp and epoetin alfa/Epogen and Procrit) and many other products. We do need to understand the risks and adverse effects associated with drugs like Read on »
Read All About It: The Disease Management Journal by JaanS Medical Doctor Posted Tue 02 Dec 2008 3:08am , Bookhart BK, Mody SH, Fournier A-A, Mallett D, Duh MS: The economic impact of pre-dialysis epoetin alfa on health care and work loss costs in chronic kidney disease: an employers' perspective. Patients who got "epo" in the months prior to starting dialysis subsequently had lower claims expense compared to those who didn't. The article's authors included Read on »
Late-breaking data to be present ... by Dr. Rubens D. Medical Doctor Posted Sun 07 Dec 2008 10:54am , a meta-analysis was conducted of 13,933 patients with cancer enrolled in 53 randomized, controlled clinical trials comparing epoetin alfa, epoetin beta, and darbepoetin alfa plus... with sickle cell disease. Recombinant Human Erythropoiesis Stimulating Agents in Cancer Patients: Individual Patient Data Meta-Analysis on Behalf of the EPO IPD Meta-Analysis Read on »

Related Searches